New imaging tracer could shed light on adrenal cholesterol

NCT ID NCT04546126

Recruiting now Knowledge-focused Sponsor: Benjamin Viglianti Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special radioactive tracer called [18F]FNP-59 to see if it can safely and clearly show cholesterol activity in the adrenal gland using PET scans. About 24 people will take part, including healthy volunteers and those with known adrenal problems. The goal is to improve imaging, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADRENAL PATHOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adrenal gland disorder hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOLESTEROL HYPERTENSION RADIOTRACER

Contacts and locations

Locations

BAMF Health, Inc.
COMPLETED

Grand Rapids, Michigan, 49503, United States
University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.